Navigation Links
Researchers will employ microscopic clay minerals to design more efficient and less toxic drugs
Date:7/5/2012

University of Granada and the Spanish Consejo Superior de Investigaciones Cientficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.

This project is based on a research on the adsortion and desorption of bioactive molecules on clay mineral surface. The goal is to design and develop new nanofunctional materials of natural origin that enable the controlled release of bioactive molecules, which is more environmentally-friendly that other synthetic systems.

This interdisciplinary research study has been funded by the University of Granada Campus of International Excellence BioTic. A total of six Andalusian research groups from different scientific fields computational modeling of clay minerals, galenic development, natural resources, environmental evaluation and in vivo studies of bioactive substances have participated in this study. In addition, an Andalusian company specialised in microencapsulated materials has also contributed to the study.

This project was coordinated by the University of Granada professor Csar Viseras Iborra and the CSIC researcher Ignacio Sainz Daz. The study embraces, among other, atomistic computational studies, the preparation and characterization of materials at microscopic level, and their application to in vivo tests.

A number of institutions and companies have contributed to this study, as the Escuela Andaluza de Salud Pblica, the Andalusian company LAIMAT and the Commissariat lnergie Atomique in Grenoble, which are all aggregated to the CEI-BioTic.

Viseras Iborra and Sainz Daz state that "the collaboration of scientific and technical experts will promote new collaborations in the future and will enable the development of new applications of clay minerals as the base of new nanofunctional materials".


'/>"/>

Contact: Cesar Viseras Iborra
cviseras@ugr.es
34-958-249-551
University of Granada
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: